GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUE:BAYN) » Definitions » Piotroski F-Score

Bayer AG (BUE:BAYN) Piotroski F-Score : 5 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Bayer AG Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bayer AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Bayer AG's Piotroski F-Score or its related term are showing as below:

BUE:BAYN' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Bayer AG was 9. The lowest was 3. And the median was 6.


Bayer AG Piotroski F-Score Historical Data

The historical data trend for Bayer AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Piotroski F-Score Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 3.00 8.00 7.00 4.00

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 4.00 4.00 5.00

Competitive Comparison of Bayer AG's Piotroski F-Score

For the Drug Manufacturers - General subindustry, Bayer AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Bayer AG's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -490660.888 + -1706426.473 + 526343.511 + 1831521.739 = ARS160,778 Mil.
Cash Flow from Operations was 125850.488 + 962082.424 + 2207335.878 + -1968885.87 = ARS1,326,383 Mil.
Revenue was 2871679.307 + 3862521.904 + 4669773.173 + 12605448.37 = ARS24,009,423 Mil.
Gross Profit was 1644897.075 + 2065339.985 + 2903747.001 + 7602646.739 = ARS14,216,631 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(26449703.4 + 31636056.338 + 43787448.567 + 45768264.995 + 109782328.804) / 5 = ARS51484760.4208 Mil.
Total Assets at the begining of this year (Mar23) was ARS26,449,703 Mil.
Long-Term Debt & Capital Lease Obligation was ARS0 Mil.
Total Current Assets was ARS36,783,367 Mil.
Total Current Liabilities was ARS28,049,755 Mil.
Net Income was -37905.223 + 75115.543 + 108510.748 + 460667.994 = ARS606,389 Mil.

Revenue was 1630560.566 + 1551975.165 + 2131143.992 + 3043412.198 = ARS8,357,092 Mil.
Gross Profit was 908071.759 + 967697.306 + 1284369.446 + 1830827.437 = ARS4,990,966 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(14873867.645 + 16382433.697 + 18023603.076 + 22177572.352 + 26449703.4) / 5 = ARS19581436.034 Mil.
Total Assets at the begining of last year (Mar22) was ARS14,873,868 Mil.
Long-Term Debt & Capital Lease Obligation was ARS0 Mil.
Total Current Assets was ARS8,380,646 Mil.
Total Current Liabilities was ARS7,274,028 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bayer AG's current Net Income (TTM) was 160,778. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Bayer AG's current Cash Flow from Operations (TTM) was 1,326,383. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=160777.889/26449703.4
=0.00607863

ROA (Last Year)=Net Income/Total Assets (Mar22)
=606389.062/14873867.645
=0.04076875

Bayer AG's return on assets of this year was 0.00607863. Bayer AG's return on assets of last year was 0.04076875. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Bayer AG's current Net Income (TTM) was 160,778. Bayer AG's current Cash Flow from Operations (TTM) was 1,326,383. ==> 1,326,383 > 160,778 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=0/51484760.4208
=0

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=0/19581436.034
=0

Bayer AG's gearing of this year was 0. Bayer AG's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=36783366.848/28049755.435
=1.31136141

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=8380646.433/7274028.001
=1.15213283

Bayer AG's current ratio of this year was 1.31136141. Bayer AG's current ratio of last year was 1.15213283. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Bayer AG's number of shares in issue this year was 982.42. Bayer AG's number of shares in issue last year was 982.42. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=14216630.8/24009422.754
=0.59212714

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4990965.948/8357091.921
=0.59721324

Bayer AG's gross margin of this year was 0.59212714. Bayer AG's gross margin of last year was 0.59721324. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=24009422.754/26449703.4
=0.90773883

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=8357091.921/14873867.645
=0.56186408

Bayer AG's asset turnover of this year was 0.90773883. Bayer AG's asset turnover of last year was 0.56186408. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Bayer AG has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Bayer AG  (BUE:BAYN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Bayer AG Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Bayer AG's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUE:BAYN) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUE:BAYN) Headlines